Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine plus ketamine for induction in pediatric difficult intubation
ChiCTR1800014686Phase 4Not yet recruiting
- Sponsor
- Shanghai Ninth People's Hospital
- Start
- Feb 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine, ketamine, midazolam and fentanyl in difficult intubation (DI) (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoint: Intubation success rate for the first time. Planned start Feb 2018; status: not yet recruiting.
02
Drugs
dexmedetomidineketaminemidazolamfentanyl
03
Conditions
difficult intubation (DI)
Beyond the preview
Go deeper on ChiCTR1800014686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800014686.